Aerie Pharmaceuticals (AERI) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Aerie Pharmaceuticals (AERI) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: September 23, 2023 (14:00)

Sector: Healthcare

The share price of Aerie Pharmaceuticals, Inc. (AERI) now

What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Aerie Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Aerie Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Aerie Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aerie Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Aerie Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Aerie Pharmaceuticals stock? When should I record a loss on Aerie Pharmaceuticals stock? What are analysts' forecasts for Aerie Pharmaceuticals stock? What is the future of Aerie Pharmaceuticals stock? We forecast Aerie Pharmaceuticals stock performance using neural networks based on historical data on Aerie Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aerie Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aerie Pharmaceuticals shares. This happens once a day.


Sell or Buy Aerie Pharmaceuticals (AERI) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the AERI stock market. Experts share their opinions on what to expect from the … Read more



Historical and forecast chart of Aerie Pharmaceuticals stock

The chart below shows the historical price of Aerie Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aerie Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Aerie Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Sep 25 15.59 15.27 16.03 4.95
Sep 26 15.92 15.68 16.51 5.28
Sep 27 16.27 15.79 16.50 4.48
Sep 28 16.59 15.95 17.21 7.85
Sep 29 16.41 15.90 16.97 6.71
Sep 30 16.93 16.33 17.21 5.34
Oct 01 16.72 16.35 17.20 5.22
Oct 02 17.10 16.61 17.62 6.07
Oct 03 17.16 16.88 17.34 2.69
Oct 04 17.14 16.81 17.54 4.33
Oct 05 16.33 16.15 16.70 3.39
Oct 06 16.10 15.82 16.57 4.78
Oct 07 16.09 15.58 16.42 5.37
Oct 08 16.35 15.77 16.94 7.41
Oct 09 16.60 16.10 17.22 7.01
Oct 10 17.08 16.51 17.29 4.71
Oct 11 17.24 16.98 17.76 4.62
Oct 12 17.53 17.13 17.91 4.55
Oct 13 16.79 16.31 17.15 5.20
Oct 14 16.58 16.19 16.95 4.66
Oct 15 16.93 16.66 17.24 3.46
Oct 16 17.20 16.84 17.44 3.52
Oct 17 17.46 17.02 17.92 5.34
Oct 18 17.86 17.62 18.23 3.45
Oct 19 17.59 16.88 18.28 8.28
Oct 20 18.20 17.82 18.56 4.14
Oct 21 18.12 17.62 18.54 5.19
Oct 22 17.57 17.05 17.77 4.22
Oct 23 17.15 16.88 17.69 4.82
Oct 24 16.31 16.06 16.71 4.06

Aerie Pharmaceuticals Daily Price Targets


Aerie Pharmaceuticals Stock Forecast 09-25-2023.

Forecast target price for 09-25-2023: $15.59.
Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 4.717%.
Pessimistic target level: 15.27
Optimistic target level: 16.03

Aerie Pharmaceuticals Stock Forecast 09-26-2023.

Forecast target price for 09-26-2023: $15.92.
Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 5.017%.
Pessimistic target level: 15.68
Optimistic target level: 16.51

Aerie Pharmaceuticals Stock Forecast 09-27-2023.

Forecast target price for 09-27-2023: $16.27.
Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 4.288%.
Pessimistic target level: 15.79
Optimistic target level: 16.50

Aerie Pharmaceuticals Stock Forecast 09-28-2023.

Forecast target price for 09-28-2023: $16.59.
Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 7.281%.
Pessimistic target level: 15.95
Optimistic target level: 17.21

Aerie Pharmaceuticals Stock Forecast 09-29-2023.

Forecast target price for 09-29-2023: $16.41.
Negative dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 6.286%.
Pessimistic target level: 15.90
Optimistic target level: 16.97

Aerie Pharmaceuticals Stock Forecast 09-30-2023.

Forecast target price for 09-30-2023: $16.93.
Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 5.066%.
Pessimistic target level: 16.33
Optimistic target level: 17.21

AERI (AERI) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Oct. 16.01 14.16 17.87 20.79
Nov. 15.40 12.97 16.57 21.75
Dec. 15.80 14.70 16.44 10.58

Aerie Pharmaceuticals forecast for this year


Aerie Pharmaceuticals Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $16.0125. Pessimistic: $14.16. Optimistic: $17.87


Aerie Pharmaceuticals Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $15.404. Pessimistic: $12.97. Optimistic: $16.57


Aerie Pharmaceuticals Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $15.8045. Pessimistic: $14.70. Optimistic: $16.44



Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 14.32 12.46 16.01 22.18
Feb 13.89 12.31 15.44 20.32
Mar 15.56 14.19 16.89 16.02
Apr 18.33 17.56 20.12 12.75
May 16.57 14.05 17.23 18.46
Jun 18.12 17.36 20.23 14.16
Jul 18.56 16.37 20.38 19.67
Aug 16.55 14.04 18.47 24.01
Sep 15.96 14.84 18.45 19.55
Oct 16.37 13.92 17.75 21.59
Nov 14.77 14.12 17.10 17.44
Dec 16.45 15.23 18.76 18.77

Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 18.23 16.99 19.50 12.90
Feb 18.78 17.05 20.77 17.90
Mar 18.74 16.00 20.27 21.07
Apr 22.15 20.02 25.34 20.98
May 21.04 19.82 22.60 12.29
Jun 21.08 18.97 22.64 16.20
Jul 22.05 19.58 24.39 19.71
Aug 18.57 16.93 19.83 14.61
Sep 20.91 18.02 22.87 21.21
Oct 21.62 18.72 23.09 18.91
Nov 25.12 22.76 29.04 21.63
Dec 28.24 25.53 29.42 13.24

Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 27.45 24.21 28.98 16.48
Feb 24.92 23.52 26.12 9.92
Mar 21.78 20.17 24.18 16.58
Apr 20.21 17.10 22.68 24.60
May 18.60 16.70 21.53 22.45
Jun 18.45 16.86 20.81 18.97
Jul 17.82 15.36 19.74 22.20
Aug 18.78 17.77 20.28 12.41
Sep 19.50 16.69 21.29 21.61
Oct 19.38 17.67 21.78 18.86
Nov 20.93 19.51 22.06 11.58
Dec 21.56 20.22 24.70 18.15

Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 19.36 18.00 21.06 14.52
Feb 18.12 15.47 19.17 19.28
Mar 16.38 13.99 17.13 18.36
Apr 15.33 14.04 16.10 12.76
May 16.96 16.04 17.91 10.42
Jun 15.57 14.20 16.75 15.24
Jul 16.69 15.69 18.96 17.25
Aug 18.22 15.85 19.28 17.77
Sep 17.75 16.43 18.60 11.64
Oct 21.19 18.22 23.23 21.53
Nov 25.22 22.19 28.95 23.34
Dec 25.02 23.66 29.02 18.45

Aerie Pharmaceuticals information and performance

Aerie Pharmaceuticals Inc. (Nasdaq: AERI) is a publicly traded, clinical stage pharmaceutical company dedicated to discovering, developing and commercializing first-class treatments for patients with glaucoma and other eye conditions.

Aerie Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.